Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T. Jacobs

Showing results (531-540 of 552) with videos related to

Pageof 56
Sort By:
Plos Neglected Tropical Diseases|July 9, 2011
SCYX-7158, an orally-active benzoxaborole for the treatment of stage 2 human African trypanosomiasisRobert T Jacobs, Bakela Nare, Stephen A Wring, et al.
Nature Genetics|November 1, 2001
Mutations at the mitochondrial DNA polymerase (POLG) locus associated with male infertilityA T Rovio, D R Marchington, S Donat, et al.
Journal of the National Cancer Institute|March 9, 2010
Case-control study of overweight, obesity, and colorectal cancer risk, overall and by tumor microsatellite instability statusPeter T Campbell, Elizabeth T Jacobs, Cornelia M Ulrich, et al.
ACS Infectious Diseases|December 27, 2019
Macrofilaricidal Benzimidazole-Benzoxaborole Hybrids as an Approach to the Treatment of River Blindness: Part 1. Amide Linked AnalogsTsutomu Akama, Yvonne R Freund, Pamela W Berry, et al.
Blood Advances|December 5, 2023
Bridging therapy with axicabtagene ciloleucel for large B-cell lymphoma: results from the US Lymphoma CAR-T ConsortiumMichael D Jain, Miriam T Jacobs, Feng Gao, et al.
Blood|November 6, 2020
Outcomes of patients with large B-cell lymphoma progressing after axicabtagene ciloleucel therapyJay Y Spiegel, Saurabh Dahiya, Michael D Jain, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 2, 2022
Severity of Cytokine Release Syndrome Influences Outcome After Axicabtagene Ciloleucel for Large B cell Lymphoma: Results from the US Lymphoma CAR-T ConsortiumMiriam T Jacobs, Michael D Jain, Feng Gao, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|May 25, 2023
AOX delays the onset of the lethal phenotype in a mouse model of Uqcrh (complex III) diseaseHoward T Jacobs, Marten Szibor, Birgit Rathkolb, et al.
British Journal of Cancer|May 12, 2011
Body mass index in early adulthood and colorectal cancer risk for carriers and non-carriers of germline mutations in DNA mismatch repair genesA K Win, J G Dowty, D R English, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 12, 2025
Memory-like NK cell differentiation, inhibitory NKG2A blockade, and improved recognition via antibody or CAR engineering combine to enhance NK cell attack against multiple myelomaAlice Y Zhou, Nancy D Marin, Sadia Afrin, et al.
Pageof 56

Showing results (531-540 of 552) with videos related to

Sort By:
Pageof 56
Plos Neglected Tropical Diseases|July 9, 2011
SCYX-7158, an orally-active benzoxaborole for the treatment of stage 2 human African trypanosomiasisRobert T Jacobs, Bakela Nare, Stephen A Wring, et al.
Nature Genetics|November 1, 2001
Mutations at the mitochondrial DNA polymerase (POLG) locus associated with male infertilityA T Rovio, D R Marchington, S Donat, et al.
Journal of the National Cancer Institute|March 9, 2010
Case-control study of overweight, obesity, and colorectal cancer risk, overall and by tumor microsatellite instability statusPeter T Campbell, Elizabeth T Jacobs, Cornelia M Ulrich, et al.
ACS Infectious Diseases|December 27, 2019
Macrofilaricidal Benzimidazole-Benzoxaborole Hybrids as an Approach to the Treatment of River Blindness: Part 1. Amide Linked AnalogsTsutomu Akama, Yvonne R Freund, Pamela W Berry, et al.
Blood Advances|December 5, 2023
Bridging therapy with axicabtagene ciloleucel for large B-cell lymphoma: results from the US Lymphoma CAR-T ConsortiumMichael D Jain, Miriam T Jacobs, Feng Gao, et al.
Blood|November 6, 2020
Outcomes of patients with large B-cell lymphoma progressing after axicabtagene ciloleucel therapyJay Y Spiegel, Saurabh Dahiya, Michael D Jain, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 2, 2022
Severity of Cytokine Release Syndrome Influences Outcome After Axicabtagene Ciloleucel for Large B cell Lymphoma: Results from the US Lymphoma CAR-T ConsortiumMiriam T Jacobs, Michael D Jain, Feng Gao, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|May 25, 2023
AOX delays the onset of the lethal phenotype in a mouse model of Uqcrh (complex III) diseaseHoward T Jacobs, Marten Szibor, Birgit Rathkolb, et al.
British Journal of Cancer|May 12, 2011
Body mass index in early adulthood and colorectal cancer risk for carriers and non-carriers of germline mutations in DNA mismatch repair genesA K Win, J G Dowty, D R English, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 12, 2025
Memory-like NK cell differentiation, inhibitory NKG2A blockade, and improved recognition via antibody or CAR engineering combine to enhance NK cell attack against multiple myelomaAlice Y Zhou, Nancy D Marin, Sadia Afrin, et al.
Pageof 56